Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/24/2025

Management of Loose Stools Related to Rituximab Infusion

Initial Management for Uncomplicated Diarrhea

  • The National Comprehensive Cancer Network recommends starting loperamide at an initial dose of 4 mg followed by 2 mg every 4 hours or after each loose stool, not exceeding 16 mg per day, for patients with mild to moderate diarrhea without complicating factors 1, 3
  • The National Comprehensive Cancer Network suggests providing oral hydration and electrolyte replacement for patients with diarrhea 2
  • The American College of Gastroenterology recommends implementing dietary modifications including a bland/BRAT diet and elimination of lactose-containing products for patients with diarrhea 1, 2
  • The European Society for Medical Oncology recommends monitoring for signs of dehydration or worsening symptoms in patients with diarrhea 1

Alternative First-Line Medications

  • The National Comprehensive Cancer Network recommends diphenoxylate/atropine 1-2 tablets PO every 6 hours as needed, maximum 8 tablets/day, as an alternative first-line medication for patients who are not already on opioids or for whom loperamide is contraindicated 2
  • The American Society of Clinical Oncology suggests considering other opioids such as tincture of opium for patients with diarrhea 4

Management for Persistent or Complicated Diarrhea

  • The National Comprehensive Cancer Network recommends considering anticholinergic agents such as hyoscyamine and atropine for patients with persistent or complicated diarrhea 2
  • The European Society for Medical Oncology suggests considering octreotide 100-500 mcg/day subcutaneous or IV, every 8 hours or by continuous infusion, for severe cases of diarrhea that don't respond to initial therapy 2, 5
  • The American College of Gastroenterology recommends hospitalization for IV fluid administration and close monitoring for patients with severe diarrhea 1, 2

Special Considerations

  • The Infectious Diseases Society of America recommends considering stool evaluation for blood, Clostridium difficile, and other infectious causes for patients with fever, blood in stool, or signs of infection 1, 5
  • The American Society of Clinical Oncology suggests considering antibiotics such as fluoroquinolones or metronidazole if infection is suspected 1, 5

Monitoring and Follow-up

  • The European Society for Medical Oncology recommends instructing patients to record the number of stools and report symptoms of life-threatening sequelae 1
  • The National Comprehensive Cancer Network suggests paying special attention to patients who are incontinent of stool due to risk of pressure ulcer formation 1
  • The American College of Gastroenterology recommends using skin barriers to prevent skin irritation caused by fecal material 1
  • The International Society of Travel Medicine notes that loperamide takes 1-2 hours to reach its therapeutic effect, so additional dosing should be spaced accordingly to avoid rebound constipation 6